Clik here to view.
Illumina ups forecast for 1Q, rejects second Roche offer
Illumina (NASDAQ:ILMN) is sitting over 1.2 percent lower today despite releasing a better than expected forecast for the first quarter. The genetic analysis instrument maker said that it should see...
View ArticleCentene, Molina back in Ohio Medicaid business – CNC, MOH, ARNA, PFE, ZLCS,...
St. Louis-based Centene Corp (NYSE:CNC) and Molina Healthcare, Inc. (NYSE:MOH) have each been rewarded Medicaid managed care agreements in Ohio in a rearranging of the before reported five winning...
View ArticleTech Biz Roundup; Tibco Software (TIBX) Fiscal Q4 Tumbles while Red Hat (RHT)...
Technology sector was the second least gainer among all sectors on Thursday but reacted positively with +0.13%. Key movement were observed in QuickLogic Corporation (NASDAQ:QUIK) and Illumina, Inc....
View ArticleEmergent Biosolutions (NYSE:EBS) Issues FY 2012 Results; Revenue Misses...
Emergent BiosolutionsInc (NYSE:EBS) on Monday reported its preliminary fiscal year 2012 financial results, projecting revenues slightly lower than Wall Street analysts’ forecasts. Biopharmaceutical...
View ArticleIllumina Inc. (NASDAQ:ILMN) Down to Knees after Roche Offer Refused – ILMN,...
Illumina Inc. (NASDAQ:ILMN)plunged almost 8.5% in premarket session on Monday following Roche Holding AG Chairman Franz Humer reported in an interview that the firm does not intend to purchase the gene...
View ArticleIllumina (NASDAQ:ILMN) Declares Sharp Boost in Fiscal Fourth Quarter Profit...
Illumina, Inc (NASDAQ:ILMN) announced a sharp boost in fiscal Q4 profit on Monday after the sale of a business unit to Amgen, Inc (NASDAQ:AMGN). Genetic analysis Instrument Company booked a $48.6...
View Article
